FDA Updates

Sublingual form approved for short-term use.

The new device will increase real-time personalization and predictive diagnostics for patients.

Anthelmintic tablet for patients 6 years of age and older.

What you need to know about the von Willebrand factor (vWF)-directed antibody fragment.

What you need to know about the new botulinum toxin product.

Approved and upcoming drugs to look forward to this year.

Approved by the FDA in September, this new drug serves as a first-line therapy for patients with particular metastatic non-small lung cancer.

GPS-based dietary prompts, continuous glucose monitors among the devices poised to revolutionize diabetes treatment and patient management. 

Research in mice has found that a vaccine may be able to help prevent the recurrence of strokes.